ISID Home
13th ICID

Welcome
Congress Committees
Scientific Program
 - 13th ICID Abstracts
 - Plenary Lectures
 - Symposia
 - Oral Presentations
 - Satellite Symposia
 - Sponsors
Congress Organization
CME Accreditation
Congress Archive

PDF Downloads

13th ICID Final Program  - General Part
 - Friday (Sessions 1-25)
 - Saturday (Sessions 26-50)
 - Sunday (Sessions 51-73)
 - Authors Index
13th ICID Abstracts
 - Abstracts Invited Presentations
 - Abstracts Oral Presentations
 - Abstracts Poster Presentations
13th ICID International Scientific Exchange Brochure  - Complete International Scientific Exchange brochure (1.8MB PDF)

ProMED-mail about us membership programs publications resources 13th ICID site map
13th ICID - Kuala Lumpur, Malaysia- June 19-22, 2008
  Held at the Kuala Lumpur Convention Centre

Symposia (updated April 27, 2008) – The program is subject to changes!
Friday | Saturday | Sunday
Influenza in Animals and People
Friday, June 20 2008, 10:15-12:15hrs, Room: Conference Hall 2
  • The Ongoing Epidemic of Highly Pathogenic Avian Influenza
    J. Lubroth (Italy)
  • Present Situation and Clinical Features of A/H5N1 Human Infection
    S. Giriputro (Indonesia)
  • Progress on Global Preparedness for Influenza Pandemic, WHO
    N. Shindo (Switzerland)
  • Progress on Pre-pandemic/Pandemic Influenza Vaccine
    M. Tashiro (Japan)
Synergy of Bacterial Flora in the Nasopharynx: Impact on Prevention Strategies
Friday, June 20 2008, 10:15-12:15hrs, Room: Plenary Theatre
supported by an educational grant from GlaxoSmithKline Biologicals
  • Clinical Implications of Nasopharyngeal Bacterial Colonization
    T. Murphy (USA)
  • Antibody Responses Following Administration of 10-Valent Pneumococcal Non-Typeable Haemophilus influenzae Protein D-Conjugate Vaccine (PHiD-CV) in Filipino Infants
    N. Bermal, E. Alberto, M. Hernandez, V. Pau (Philippines), A. Fanic (Belgium), S. Gatchalian (Philippines), I. Dieussaert, L. Schuerman (Belgium)
  • Impact Estimate of the 10-Valent Pneumococcal Non-Typeable Haemophilus influenzae Protein D-Conjugate Vaccine (PHiD-CV) on Invasive Pneumococcal Disease (IPD) in Middle East and Asian Countries
    N. Begg (Belgium)
  • Otitis Media: Why Is it so Difficult to Treat or Prevent?
    G. Navarro-Locsin (Philippines)
  • Preventing Pneumonia: Lessons and Future Implications
    R. Dagan (Israel)
The Changing Landscape of HIV Therapies
Friday, June 20 2008, 10:15-12:15hrs, Room: Banquet Hall
supported by an educational grant from MSD
  • The Challenge of Treating HIV in Asia
    C. Lee (Malaysia)
  • The Changing Landscape of HIV Therapies: Increased Choices, Increased Challenges
    A. Carr (Australia)
  • ISENTRESS, the First of a New Class of Integrase Inhibitors: Clinical Overview
    C. Hicks (USA)
Infectious Diarrhea and Enteric Fever
Friday, June 20 2008, 10:15-12:15hrs, Room: 304/305
  • Close Encounters of the ETEC-type
    A. Cravioto (Bangladesh)
  • Typhoid Vaccines as Routine Public Health Tools for Developing Countries: An Idea Whose Time Has Come
    J. Clemens (Republic of Korea)
  • The New Emerging Strain of Cholera: One Step Ahead of Genomics
    G. Balakrish Nair (India)
  • Rotavirus and Rotavirus Vaccines: Are We There Yet?
    R. Glass (USA)
return to top
Beyond Cardiovascular Disease: Statins and Cholesterol in Infectious Diseases
Friday, June 20 2008, 10:15-12:15hrs, Room: 302/303
  • Statins and Sepsis: Multiple Modifications at Multiple Levels
    M. Terblanche (United Kingdom)
  • Statins in Animal Models of Infection
    M.W. Merx (Germany)
  • Observational Studies of Statins in Bacteremia
    P. Kruger (Australia)
  • Parasites as host cholesterol consumers: The special case of Toxoplasma gondii
    K.A. Joiner (USA)
The Challenge of Multiple- Resistant Gram-Negative Bacteria
Friday, June 20 2008, 15:45-17:45hrs, Room: Conference Hall 2
  • Clinical and Public Health Impact of Multiple-Resistant Gram-Negative Bacteria
    Y. Carmeli (Israel)
  • Epidemiology of Multiple-Resistant Gram-Negative Bacteria in Europe and North America
    A. Srinivasan (USA)
  • Burden and Future Gram-Negative Resistance in Asia/Australia
    D.L. Paterson (Australia)
  • How to Prevent the Spread of Multiple-Resistant Gram-Negative Bacteria in the Hospital Setting
    S. Harbarth (Switzerland)
Overcoming the Challenges of Pertussis Control
Friday, June 20 2008, 15:45 - 17:45hrs, Room: Plenary Theatre
supported by an educational grant from Sanofi Pasteur
  • Burden of Pertussis Worldwide: Strategies to Reinforce Pertussis Control in Children, Adolescents, and Adults
    K. Forsyth (Australia)
  • Pertussis Control in Infants and Children
    U. Thisyakorn (Thailand)
  • The Role of Pertussis Booster Vaccinations in Adolescents and Adults
    D. Johnson (USA)
New Perspectives on Vaccine-preventable Diseases in Adults: Pneumococcal Disease and Herpes Zoster
Friday, June 20 2008, 15:45-17:45hrs, Room: Banquet Hall
supported by an educational grant from MSD
  • Opening Remarks - Adult Immunisation: Some Thoughts
    J. Hanna (Australia)
  • Pneumococcal Disease and a Pneumococcal Polysaccharide Vaccine for Older Adults
    M. Mohan (India)
  • A Vaccine for the Prevention of Herpes Zoster and Its Complications
    M. Levin (USA)
  • Herpes Zoster and Post Herpetic Neuralgia (PHN) - The Taiwan Perspective
    C.C. Yang (Taiwan)
  • Herpes Zoster (HZ) and Post-herpetic Neuralgia (PHN): Burden of Illness, Healthcare Utilization, and Costs; the Thai Perspective
    P. Pitisuttihum (Thailand)
return to top
New Directions in the Treatment of Fungal Infections
Friday, June 20 2008, 15:45-17:45hrs, Room: 304/305
  • The Changing Epidemiology of Fungal Infection: New Pathogens and Problems
    B. Sathapatayavongs (Thailand)
  • Pharmacodynamics of Antifungal Drugs: A Strategy to Optimize Efficacy
    D. Andes (USA)
  • New Generation Triazoles: What Do They Offer and When Do We Need Them?
    T.C. Sorrell (Australia)
  • Understanding the Similarities and Differences of Existing and Emerging Echinocandins
    M.A. Slavin (Australia)
Emergence of EV71 in the Asia Pacific in the Last Decade
Friday, June 20 2008, 15:45-17:45hrs, Room: 302/303
  • Epidemiology of EV71 Outbreaks in the Region in the Past Decade
    A. Kiyu (Malaysia)
  • Clinical Studies on EV71 Neurological Disease
    M.H. Ooi (Malaysia)
  • Mouse and Non-human Primate Models for EV71 Disease
    H. Shimizu (Japan)
  • Update on the Molecular Epidemiology of Human Enterovirus 71 in Taiwan Since 1998
    H.S. Wu (Taiwan)
Evidence-Based Infection Control: What is New?
Saturday, June 21 2008, 10:15-12:15hrs, Room: Conference Hall 2
  • CA-MRSA as a Hospital Pathogen
    R. Wenzel (USA)
  • Preventing Catheter-Related Bloodstream Infections
    T.M. Perl (USA)
  • Relevant Vaccines for Health Care Workers
    S. Ponce de Leon (Mexico)
  • Prevention of Surgical Infections
    A. Widmer (Switzerland)
New Generation Multivalent Vaccines Designed to Do More
Saturday, June 21 2008, 10:15-12:15hrs, Room: Plenary Theatre
supported by an educational grant from MSD
  • Multivalent Protection Against a Severe Pediatric Disease - Rotavirus
    C. Christie (Jamaica)
  • Long Term Benefits of the Quadrivalent Human Papillomavirus Vaccine (HPV)
    S. Garland (Australia)
  • Value of the Quadrivalent HPV Vaccine
    L.L. Villa (Brazil)
  • Review of Global and Regional Recommendations for the Pentavalent Rotavirus Vaccine and Quadrivalent HPV Vaccine
    L.L. Villa (Brazil), C. Christie (Jamaica)
return to top
Intradermal Route: The Natural Pathway for Improved Influenza Vaccination
Saturday, June 21 2008, 10:15 - 12:15hrs, Room: Banquet Hall
supported by an educational grant from Sanofi Pasteur
  • Global Use of Seasonal Influenza Vaccine
    D.S. Fedson (France)
  • The Potential Benefits of Intradermal Vaccination
    B.J. Ward (Canada)
  • Clinical Development of a Seasonal Influenza Vaccine by Intradermal Micro-injection
    M. Saville (France)
  • From Immunogenicity to Vaccine Efficacy: Insights from Statistical and Causal Models
    M.E. Halloran (USA)
Viral Hepatitis
Saturday, June 21 2008, 10:15-12:15hrs, Room: 304/305
  • Treatment of Hepatitis C: Yesterday, Today, and Tomorrow
    K.R. Reddy (USA)
  • Managing Drug Resistance in the Hepatitis B-Infected Patient
    S.S. Tan (Malaysia)
  • Treatment of Hepatitis C in the HIV-Infected Subject
    N. Terrault (USA)
  • Metabolic Abnormalities in HIV Infection
    A. Sanyal (USA)
Orientia tsutsugamushi: a Neglected Pathogen
Saturday, June 21 2008, 10:15-12:15hrs, Room: 302/303
  • Genome Analysis
    A.C. Darby (United Kingdom)
  • Genetic Variability of Orientia tsutsugamushi
    P.E. Fournier (France)
  • The Use of Genomics for the Early Diagnosis of Scrub Typhus and Other Systemic Infectious Diseases
    D. Relman (USA)
  • Vector and Epidemiology
    F. Mahara (Japan)
The New Face of Clostridium difficile-Associated Disease (CDAD)
Saturday, June 21 2008, 15:45-17:45hrs, Room: Conference Hall 2
  • The spread of hypervirulent Clostridium difficile PCR Ribotype 027 in Europe.
    E.J. Kuijper (Netherlands)
  • Diagnosing Clostridium difficile-Associated Diseases: The State of the Art
    C.E. Nord (Sweden)
  • Preventing New and Recurrent CDAD
    J. Bartlett (USA)
  • Managing CDAD: Current and Upcoming Approaches
    J. Pepin (Canada)
return to top
Cervical Cancer Vaccination: The Need for Strong and Sustained Protection
Saturday, June 21 2008, 15:45 - 17:45hrs, Room: Plenary Theatre
supported by an educational grant from GlaxoSmithKline Biologicals
  • HPV Types 16, 18, 45 and 31: The Most Important Oncogenic HPV Types Worldwide
    F.X. Bosch (Spain)
  • The Value of New Adjuvant Technology
    F. Zepp (Germany), N. Garçon (Belgium)
  • Cervical Cancer Vaccination: Protection When and Where It Counts
    T. F. Schwarz (Germany)
  • Implementation of Cervical Cancer Vaccination. Reaching Girls and Women: Challenges and Opportunities
    S-K. Tay (Singapore)
Macrolides - Yesterday, Today and Tomorrow
Saturday, June 21 2008, 15:45-17:45hrs, Room: Banquet Hall
supported by an educational grant from Pliva
  • RTI: Treatment Challenges
    S. Esposito (Italy), B. Barsic (Croatia)
  • Chlamydia trachomatis: Area Under the Iceberg
    I. Sziller (Hungary)
  • Acne vulgaris - Old/New Treatment?
    H. Zelenkova (Slovakia)
  • Acute Infectious Gastroenterocolitis: Use or Not to Use Antibiotics?
    D. Vukelic (Croatia)
Biodiversity
Saturday, June 21 2008, 15:45-17:45hrs, Room: 304/305
  • Diversity of Human Microbial Pathogens and Commensals
    D. Relman (USA)
  • Evolution of Diversity in Pathogen Populations
    M. Eppinger (USA)
  • Retroviral Biodiversity: Practical Consequences for HIV Treatment and Prevention
    M. Wainberg (Canada)
  • Diversity at the Virus-Bacterium Interface
    D. Raoult (France)
AIDS in Asia: The New Tsunami
Saturday, June 21 2008, 15:45-17:45hrs, Room: 302/303
  • AIDS in India
    S. Solomon (India)
  • AIDS in Thailand
    P. Phanuphak (Thailand)
  • AIDS Control in China
    Y. Shao (China)
  • AIDS in Malaysia
    A. Kamarulzaman (Malaysia)
return to top
Antibiotic Practices and Resistance in Areas of Unstable Health Infrastructures
Saturday, June 21 2008, 15:45-17:45hrs, Room: 301
  • Antimicrobial Practices and Resistance in Pediatrics in an HIV Endemic Area of Cambodia
    J. Benca, L. Seng Duong (Cambodia)
  • Antibiotic Practices and Resistance in Genocide Areas of Darfur and Southern Sudan
    V. Krcmery, S. Njabmi (Slovakia)
  • Antibiotic Practices and Resistance in a Rural Haitian Population Isolated by Previous Civil War Conflicts
    A. Augustinova (Haiti), K. Holeckova (Slovakia)
  • Antibiotic Practices and Policies in Slums of Nairobi and Among Economic Refugees in Turbana Area
    V. Sladeckova, J.M. Muli (Kenya)
Community-Acquired MRSA: What in the World is Going on?
Sunday, June 22 2008, 10:15-12:15hrs, Room: Conference Hall 2
  • The Origin and Evolution of MRSA
    B. Kreiswirth (USA)
  • Evasion of Innate Host Defense by Staphylococcus aureus
    F DeLeo (USA)
  • Microbial Pathogenesis of Community-Acquired MRSA Infections
    T.J. Foster (Ireland)
  • Clinical Aspects of the Community-Acquired MRSA Epidemic
    H. Chambers (USA)
Partnering in R&D to Develop New Drugs for the Most Neglected Diseases
Sunday, June 22 2008, 10:15-12:15hrs, Room: Plenary Theatre
supported by an educational grant from DNDi
  • Current Discovery Research and Most Promising Avenues, Including Anti-Trypanosomal Screens of Kitasato Natural Products
    H. Yamada (Japan)
  • Progress in Discovery and Development of Drug to Treat Dengue Fever
    P. Herrling (Switzerland)
  • Improving Malaria Treatment and Compliance - Examining Clinical Evidence on a New Fixed-Dose Combination of Artesunate and Mefloquine
    E. Ashley (Thailand)
  • Efficacy and Safety of Artesunate-Amodiaquine Fixed-Dose Combination in India
    N. Valecha (India)
  • New Treatment Options for Visceral Leishmaniasis: What's Available and in Clinical Development
    P. Olliaro (Switzerland)
Extensively Drug-Resistant TB: New Name or New Problem
Sunday, June 22 2008, 10:15-12:15hrs, Room: Banquet Hall
  • The Epidemiology of XDR TB in KwaZulu Natal South Africa: A New name or a New Problem
    R. Rustomjee (South Africa)
  • MDR-TB and XDR-TB in Asia
    T.E. Tupasi (Philippines)
  • Rapid Diagnosis of MDR-TB in Low-resource Settings
    D.A.J. Moore (United Kingdom)
  • The Epidemiology of MDR-TB in Peru
    E. Gotuzzo (Peru)
return to top
Controlling Japanese Encephalitis: Advances in Detection and Prevention
Sunday, June 22 2008, 10:15-12:15hrs, Room: 304 / 305
supported by an educational grant from PATH
  • Measuring Japanese Encephalitis Disease Burden: Challenges in Surveillance and Diagnostics
    M. Fischer (USA)
  • Japanese Encephalitis in Indonesia: New Findings on Geographical Extent and Disability from the Disease
    E.R. Sedyaningsih (Indonesia)
  • The Landscape of New Vaccines for Japanese Encephalitis: Country-Level Strategies for Introduction
    M.R.N. Abeysinghe (Sri Lanka)
  • Japanese Encephalitis Control: What Can Be Achieved?
    J. Hombach (Switzerland)
International Perspectives on Palliative Care for People with HIV/AIDS
Sunday, June 22 2008, 10:15-12:15hrs, Room: 302/303
  • International Perspectives on Hospice and Palliative Care for HIV/AIDS
    S.R. Connor (USA)
  • Clinical Issues in Palliative Care for HIV/AIDS
    E. Hamzah (Malaysia)
  • Successful Development in Hospice and Palliative Care in Asia
    C.R. Goh (Singapore)
  • National and International Measurement Opportunities
    D. Casarett (USA)
Treatment of Acute Otitis Media in Children - Never Simple
Sunday, June 22 2008, 15:45-17:45hrs, Room: Conference Hall 2
  • How to Evaluate Response to Treatment in AOM
    D.P. McCormick (USA)
  • Summary of Studies With New Antibiotics in AOM in Last Decade - Where Are We?
    A. Arguedas (Costa Rica)
  • What Do Antibiotics Really Do In AOM?
    R. Dagan (Israel)
  • Delayed Antibiotic Treatment of AOM - Risks and Benefits
    P. Little (United Kingdom)
Treatment of Infections Caused by Highly Drug-Resistant Bacteria
Sunday, June 22 2008, 15:45-17:45hrs, Room: Banquet Hall
  • Multi-resistant Enterobacteriaceae
    J. Turnidge (Australia)
  • Carbapenem-resistant Pseudomonas and Acinetobacter
    A. Kamarulzaman (Malaysia)
  • Ceftriaxone-resistant Salmonella
    A. Gupta (USA)
  • Fluroquinolone-resistant Gonorrhea
    P.R. Hsueh (Taiwan)
return to top
Update on Clinically Significant Anaerobes
Sunday, June 22 2008, 15:45-17:45hrs, Room: 304/305
  • Antimicrobial Resistance Among Anaerobes -The European Experience
    C.E. Nord (Sweden)
  • Clostridium difficile Type O27, Coping with a More Virulent Strain
    E.J. Kuijper (Netherlands)
  • Molecular Biology of Protein Glycosylation in the Symbiotic Anaerobe Bacteroides Fragilis
    C.M. Fletcher (USA)
  • Anaerobes As Biofilms
    G. Donelli (Italy)
Antiretrovirals for Prevention of HIV
Sunday, June 22 2008, 15:45-17:45hrs, Room: 302/303
  • Can Expanded Treatment Slow the AIDS Epidemic? The Public Health Perspective
    N. Kumarasamy (India)
  • Can Expanded Treatment Slow the AIDS Epidemic? The Behavioral Scientist's View
    K. Chillag (USA)
  • Antivirals in Uninfected People: PrEP and PEP
    A.E. Grulich (Australia)
  • Antivirals for HIV Prevention
    K. Mayer (USA)
Emerging Rickettsioses in Asia
Sunday, June 22 2008, 15:45-17:45hrs, Room: 301
  • Spotted Group Rickettsioses in Asia
    O. Mediannikov (Russia)
  • Scrub Typhus
    Y. Suputtamongkol (Thailand)
  • Different Clinical Expression of Murine Typhus and Scrub Typhus
    P.N. Newton (Lao People's Democratic Republic)
  • Diagnosis of Rickettsioses
    D. Raoult (France)

return to top

 




ProMED-mail | about us | membership | programs | publications
resources | 13th ICID | sitemap | home

1330 Beacon Street, Suite 228, Brookline MA 02446 · USA
Phone: (617) 277-0551 · Fax: (617) 278-9113 · info@isid.org
Contact Us

©2001 International Society for Infectious Diseases
All Rights Reserved.
Read our privacy guidelines.
Use of this web site and related services is governed by the Terms of Service.